Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PET in generalized anxiety disorder.

J C Wu1, M S Buchsbaum, T G Hershey

  • 1Department of Psychiatry and Human Behavior, University of California, Irvine 92717.

Biological Psychiatry
|June 15, 1991
PubMed
Summary

Positron emission tomography (PET) revealed altered brain glucose metabolism in generalized anxiety disorder (GAD) patients, particularly in the basal ganglia. Benzodiazepine treatment did not normalize these metabolic patterns.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Symposium on Pellagra.

Buffalo medical journal·2023
Same author

Some Observations on Gastric and Duodenal Ulcer.

Buffalo medical journal·2023
Same author

Antikamnia.

The Southern medical record·2022
Same author

The Real and Relative Value of Our Recent Antipyretics.

Atlanta medical and surgical journal (1884)·2022
Same author

Perinatal fluoxetine exposure results in social deficits and reduced monoamine oxidase gene expression in mice.

Brain research·2019
Same author

Incidence of variations in human cadaveric renal vessels.

Folia morphologica·2017

Area of Science:

  • Neuroscience
  • Psychiatry
  • Medical Imaging

Background:

  • Generalized anxiety disorder (GAD) is a prevalent condition with complex neurobiological underpinnings.
  • Previous research suggests alterations in brain metabolism may be associated with anxiety disorders.

Purpose of the Study:

  • To investigate cerebral glucose metabolism patterns in patients with GAD compared to healthy controls.
  • To examine the effects of benzodiazepine medication and placebo on brain metabolism during different cognitive tasks.

Main Methods:

  • Positron emission tomography (PET) was used to measure cerebral glucose metabolism in 18 GAD patients and 15 controls.
  • Patients underwent PET scans during passive viewing (off medication) and active vigilance tasks (before and after treatment).
  • Treatments included benzodiazepine medication or placebo.

Related Experiment Videos

Main Results:

  • GAD patients exhibited lower absolute metabolic rates in basal ganglia and white matter compared to controls.
  • Relative metabolism was increased in specific cortical areas (occipital, temporal, frontal) in GAD patients.
  • Benzodiazepine therapy decreased absolute metabolic rates in cortical, limbic, and basal ganglia regions but did not normalize GAD-related metabolic patterns.
  • Anxiety score changes correlated with metabolic changes in the limbic system and basal ganglia in the placebo group.

Conclusions:

  • The basal ganglia show altered metabolism in GAD and may play a role in anxiety.
  • Benzodiazepine treatment affects brain metabolism but does not restore normal patterns in GAD.
  • Further research is needed to understand the neurobiology of GAD and treatment effects.